Losy J, Michałowska-Wender G, Wender M
Katedry i Kliniki Neurologii AM, Poznaniu.
Neurol Neurochir Pol. 1993 Nov-Dec;27(6):803-9.
The aim of the study was to determine IgG subclasses of MBP antibodies in patients with multiple sclerosis. The enzyme-linked immunosorbent assay (ELISA) with monoclonal antibodies against human IgG subclasses was applied. Anti-MBP antibodies were found in the CSF of 16% and in the sera of 20% patients with MS. MBP antibodies belonged to IgG1, IgG2 and IgG3 subclasses (in the CSF) and to IgG1 and IgG3 subclasses (in the sera). The role of MBP antibodies in context of their IgG subclasses distribution is discussed.
本研究的目的是确定多发性硬化症患者中髓鞘碱性蛋白(MBP)抗体的IgG亚类。应用了针对人IgG亚类的单克隆抗体的酶联免疫吸附测定(ELISA)。在16%的多发性硬化症患者脑脊液和20%的患者血清中发现了抗MBP抗体。MBP抗体属于IgG1、IgG2和IgG3亚类(脑脊液中)以及IgG1和IgG3亚类(血清中)。讨论了MBP抗体在其IgG亚类分布背景下的作用。